5768 AMS PADD ATTA 369

  

SB 5768 - S AMD 436

By Senator Padden

NOT ADOPTED 04/14/2023

On page 4, after line 40, insert the following:

"NEW SECTION. Sec. A new section is added to chapter 18.130 RCW to read as follows:

If the United States food and drug administration rescinds approval for mifepristone, any licensee subject to this chapter must obtain written informed consent from a patient indicating that they understand the side effects of the drug, including heavy bleeding, hemorrhaging, cramping, infection, sepsis, and other severe outcomes, and that the drug is not approved by the food and drug administration before prescribing or dispensing the drug."

Renumber the remaining sections consecutively and correct any internal references accordingly.

SB 5768 - S AMD

By Senator Padden

On page 1, line 4 of the title, after "72.09 RCW;" insert "adding a new section to chapter 18.130 RCW;"

EFFECT:  If the FDA rescinds approval for mifepristone, requires health care providers to obtain informed consent informing the patients of the side effects of the drug, including heavy bleeding, hemorrhaging, cramping, infection, sepsis, and other severe outcomes, and that the drug is not FDA approved before dispensing or prescribing it.  

--- END ---